Pediatric patients with multiple sclerosis (MS) face significant challenges transitioning to adult care, risking treatment delays and long-term health outcomes.

New development at the University of Sheffield will double the research capacity of the world-leading research facility, accelerating the progress of breakthrough treatments for degenerative ...

Major autism breakthrough could revolutionise treatments and care - The ‘person-centred’ research found four distinct subtypes of autism that researchers believe could be vital in understanding the bi ...

A new study reveals that neural stem cell grafts can generate new myelin in the central nervous system, offering hope for ...

The National Multiple Sclerosis Society (NMSS) announced a number of new funding opportunities aimed to bolster MS research and training. Support originates both from the Society and outside entities.

WATCH: Medical breakthrough: immunotherapy for cancer being used as a treatment in Memphis MEMPHIS, Tenn. - A promising new study is changing the way doctors think about treating certain cancers.

A novel program provided evidence that addressing long-known disparities in high-efficacy multiple sclerosis (MS) treatment for minority populations is a solvable problem.

Life expectancy for those with secondary progressive multiple sclerosis may be a bit lower than for the larger population, but new treatments offer improvements.

Should multiple sclerosis (MS) patients stop disease-modifying treatment (DMT) as they get older? The answer depends on several factors, noted John Corboy, MD, of the Rocky Mountain MS Center at ...

Conventional treatment simply targets symptoms, often using steroids to suppress immune activity. Throne’s approach, however, uses its Stem Cell Educator (SCE) therapy.